A PHASE III, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF GLOFITAMAB IN COMBINATION WITH GEMCITABINE

Clinical Trial Grant

Duke Scholars

Principal Investigator Matthew Stuart McKinney Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Start Date

December 8, 2021

End Date

December 30, 2026

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Start Date

December 8, 2021

End Date

December 30, 2026